Moreover, in the present study, we further explored the inflammatory and oxidative urinary biomarkers in these IC/BPS patients and found that patients without satisfactory treatment outcomes had higher MCP-1 and 8-isoprostane levels. Here, CCL2 is linked to Bartsocas-Papas syndrome 1.